COVID-19 conundrum: clinical phenotyping based on pathophysiology as a promising approach to guide therapy in a novel illness
Open Access
- 1 August 2020
- journal article
- letter
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 56 (2), 2002135
- https://doi.org/10.1183/13993003.02135-2020
Abstract
The current evidence of COVID-19 pathophysiology supports the idea of specific phenotypes, and clinical phenotyping may be valuable to guide therapy.This publication has 25 references indexed in Scilit:
- Covid-19 in Critically Ill Patients in the Seattle Region — Case SeriesThe New England Journal of Medicine, 2020
- COVID-19 Does Not Lead to a “Typical” Acute Respiratory Distress SyndromeAmerican Journal of Respiratory and Critical Care Medicine, 2020
- Plasminogen improves lung lesions and hypoxemia in patients with COVID-19QJM: An International Journal of Medicine, 2020
- Chest CT manifestations of new coronavirus disease 2019 (COVID-19): a pictorial reviewEuropean Radiology, 2020
- Acute respiratory distress syndromeNature Reviews Disease Primers, 2019
- The physiological basis of pulmonary gas exchange: implications for clinical interpretation of arterial blood gasesEuropean Respiratory Journal, 2014
- Gas exchange and ventilation–perfusion relationships in the lungEuropean Respiratory Journal, 2014
- Acute Respiratory Distress SyndromeJAMA, 2012
- Diffuse microvascular pulmonary thrombosis associated with primary antiphospholipid antibody syndromeEuropean Respiratory Journal, 1997
- Hemorrhage and resuscitation induce alterations in cytokine expression and the development of acute lung injury.American Journal of Respiratory Cell and Molecular Biology, 1994